To include your compound in the COVID-19 Resource Center, submit it here.

Found money

NPS has more to spend on pipeline thanks to financial engineering with Amgen

Found money

Rather than dip into its $202 million war chest to retire $133 million of debt, NPS Pharmaceuticals Inc. (NASDAQ:NPSP) is getting fronted the money from partner Amgen Inc. (NASDAQ:AMGN) as an advance on royalties from

Read the full 365 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE